secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clearside Biomedical, Inc. (CLSDQ)
CIK:        0001539029
Form:       8-K
Filed at:   2025-10-07T23:59:59+00:00
Accession:  0001193125-25-233470
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Clearside Biomedical regains Nasdaq minimum bid price compliance via reverse split
--------------------------------------------------------------------------------

- Received Nasdaq Panel letter on Oct 6, 2025 confirming compliance with Minimum Bid Price Requirement.
- Compliance achieved by maintaining closing bid at $1.00+ for 10 consecutive business days after reverse stock split.
- Reverse stock split effective Sept 12, 2025 was approved by stockholders and implemented to cure non-compliance.
- Non-compliance notice originally received Feb 7, 2025; delisting hearing held Sept 16, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1539029/000119312525233470/0001193125-25-233470-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1539029/000119312525233470/clsd-20251007.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-233470

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer